Oberthür, C. A., Juraeva, D., Eils, R., Westermann, F., & Brors, B. (2015). Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers. Clinical cancer research, 21(8), . https://doi.org/10.1158/1078-0432.CCR-14-0817
Chicago-Zitierstil (17. Ausg.)Oberthür, Carl André, Dilafruz Juraeva, Roland Eils, Frank Westermann, und Benedikt Brors. "Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers." Clinical Cancer Research 21, no. 8 (2015). https://doi.org/10.1158/1078-0432.CCR-14-0817.
MLA-Zitierstil (9. Ausg.)Oberthür, Carl André, et al. "Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers." Clinical Cancer Research, vol. 21, no. 8, 2015, https://doi.org/10.1158/1078-0432.CCR-14-0817.